CarthroniX Completes Convertible Note Financing - Press Release
Proceeds Will Support Pre-clinical Development and Clinical Advancement of its Lead Candidate, CX-011, for the Treatment of Mild to Moderate Knee Oste
United States Ron Ellis Pacira Biosciences Pacira Biosciences Inc Carthronix Inc Proceeds Will Support Pre Clinical Development
Source: wiredprnews.com